DBV Technologies | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amarin USD 650.22M 51.62M 2024-09
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
DBV Technologies USD 68.76M 21.2M 2024-09
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
Incyte USD 3.23B 7.24M 2025-03
Insmed USD 1.4B 218.97M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
PTC Therapeutics USD 2.32B 950.88M 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03



DBV Technologies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.